longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

TAWNF

TAWNF
----

LongbridgeAI

GDS Supercharges AI Infrastructure Bets as Geron Secures Key FDA Node

Global Report
Jul 15, 2026 at 09:14 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

A surge in AI-driven capital expenditures and pivotal biotech milestones are reshaping fundamental narratives across multiple sectors in 2026. GDS Holdings is pouring billions into computing clusters, while Geron transitions into a commercial-stage entity following its landmark FDA approval.

The intersection of accelerating artificial intelligence investments and critical clinical readouts has created a bifurcated tape for several mid-to-small cap entities in early 2026, as operational delivery begins to eclipse broader macro headwinds.

GDS Holdings (GDS.US) reported a 23.6% YoY jump in Q1 net revenue to CNY 3.36 billion. Capitalizing on unabated AI infrastructure demand, the data center operator locked in a record 200MW in new orders and outlined a massive CNY 30 billion capital injection for a green-energy computing cluster in Ulanqab, supporting a recent upswing in its equity performance.

Software and financial services are similarly leaning into the generative AI pivot. CXApp (CXAI.US) unveiled its CXAI 2.0 enterprise platform and closed the EngineRoom acquisition, a move management projects will triple its annualized revenue run-rate past USD 12 million. Overseas, Danske Bank (DNKEY.US) is deepening an AWS pact to aggressively deploy AI solutions while sustaining a steady pace of share buybacks.

The biotech landscape witnessed significant de-risking events. Geron Corp. (GERN.US) crossed a massive commercial threshold in June as the FDA cleared RYTELO, marking the first approved telomerase inhibitor for specific MDS patients. Concurrently, Allogene Therapeutics (ALLO.US) navigated a C-suite transition while posting positive interim efficacy for its ALPHA3 phase 2 trial, bolstering its balance sheet with a USD 200 million public offering.

In legacy sectors, falling input costs are dictating operational strategy. Thai Airways (TAWNF.US) slashed fares by 20% to 30% on select routes as aviation fuel cooled from previous peaks, building on a 12.3% YoY rise in Q1 top-line. Advanced materials supplier Avient Corp. (AVNT.US) delivered a Q1 adjusted EPS of USD 0.83, beating estimates on the back of resilient pricing power and cost controls.

In the digital creator space, GameSquare Holdings (GAME.US) saw its Q1 revenue nearly double, driven by aggressive M&A integration including the TubeBuddy platform. Elsewhere, entities with limited near-term catalyst visibility, such as Aixcrypto Holdings (AIXC.US) and Cantor Equity Partners II (CEPT.US), continue to navigate structural recalibrations in a liquidity-constrained tape.

Login to unlock1,766characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

GDS

GDS

USGDS

-0.77%

CXApp

CXApp

USCXAI

-3.73%

Danske Bank

Danske Bank

USDNKEY

+1.13%